{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:04:57Z","timestamp":1788923097708,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cpm.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T20:51:11Z","timestamp":1417207871000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bioengineered Alternative Tissues in Diabetic Wound Healing"],"prefix":"10.1016","volume":"32","author":[{"given":"Caitlin S.","family":"Garwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpm.2014.09.004_bib1","unstructured":"World Health Organization. The top 10 causes of death. Fact sheet 310, 2014. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/. Accessed April 15, 2014."},{"key":"10.1016\/j.cpm.2014.09.004_bib2","series-title":"IDF Diabetes Atlas, 6th edition","author":"International Diabetes Federation","year":"2013"},{"key":"10.1016\/j.cpm.2014.09.004_bib3","series-title":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"10.1016\/j.cpm.2014.09.004_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"issue":"S5","key":"10.1016\/j.cpm.2014.09.004_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders: a clinical practice guideline","volume":"45","author":"Frykberg","year":"2006","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"5","key":"10.1016\/j.cpm.2014.09.004_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jdiacomp.2014.04.011","article-title":"The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk","volume":"28","author":"Martins-Mendes","year":"2014","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.cpm.2014.09.004_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cpm.2007.03.011","article-title":"Bioengineered alternative tissues and hyperbaric oxygen in lower extremity wound healing","volume":"24","author":"Kim","year":"2007","journal-title":"Clin Podiatr Med Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib8","series-title":"Surgical reconstruction of the diabetic foot & ankle","first-page":"100","article-title":"Bioengineered alternative tissues for the surgical management of diabetic foot ulceration","author":"Steinberg","year":"2009"},{"issue":"4","key":"10.1016\/j.cpm.2014.09.004_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0039-6109(16)40983-7","article-title":"Wound healing","volume":"56","author":"Schilling","year":"1976","journal-title":"Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.cpm.2014.09.004_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpm.2013.09.010","article-title":"Bioengineered alternative tissues","volume":"31","author":"Cook","year":"2014","journal-title":"Clin Podiatr Med Surg"},{"issue":"2","key":"10.1016\/j.cpm.2014.09.004_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semvascsurg.2012.04.008","article-title":"Wound care: biofilm and its impact on the latest treatment modalities for ulcerations of the diabetic foot","volume":"25","author":"Kim","year":"2012","journal-title":"Semin Vasc Surg"},{"issue":"1","key":"10.1016\/j.cpm.2014.09.004_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-3468(05)80167-8","article-title":"Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats","volume":"25","author":"Hennessey","year":"1990","journal-title":"J\u00a0Pediatr Surg"},{"issue":"7","key":"10.1016\/j.cpm.2014.09.004_bib13","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2337\/diabetes.50.7.1627","article-title":"Glucose effects on skin keratinocytes: implications for diabetes skin complications","volume":"50","author":"Spravchikov","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.cpm.2014.09.004_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/diacare.15.2.256","article-title":"Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes","volume":"15","author":"Marhoffer","year":"1992","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cpm.2014.09.004_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/ciia.2007.2.1.93","article-title":"A\u00a0review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers","volume":"2","author":"Zaulyanov","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.cpm.2014.09.004_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1523-1747.2002.01865.x","article-title":"Wounding of bioengineered skin: cellular and molecular aspects after injury","volume":"119","author":"Falanga","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cpm.2014.09.004_bib17","first-page":"65","article-title":"Integra bilayer wound matrix application for complex lower extremity soft tissue reconstruction","volume":"24","author":"Kim","year":"2014","journal-title":"Surg Technol Int"},{"key":"10.1016\/j.cpm.2014.09.004_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/diacare.24.2.290","article-title":"Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial","volume":"24","author":"Veves","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2014.09.004_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/PRS.0b013e318254b1ea","article-title":"A\u00a0systematic review of skin substitutes for foot ulcers","volume":"130","author":"Felder","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib20","first-page":"698","article-title":"Graftskin treatment of difficult to heal diabetic foot ulcers: one center\u2019s experience","volume":"28","author":"Sams","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1534734609331597","article-title":"European and Australian Apligraf diabetic foot ulcer study group. Apligraf in the treatment of neuropathic diabetic foot ulcers","volume":"8","author":"Edmonds","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.cpm.2014.09.004_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2165\/00019053-200321160-00003","article-title":"The cost effectiveness of Apligraf treatment on diabetic foot ulcers","volume":"21","author":"Redekop","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cpm.2014.09.004_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2337\/diacare.19.4.350","article-title":"Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers","volume":"19","author":"Gentzkow","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2014.09.004_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1525-1594.1997.tb00476.x","article-title":"A\u00a0metabolically active human dermal replacement for the treatment of diabetic foot ulcers","volume":"21","author":"Naughton","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.cpm.2014.09.004_bib25","first-page":"175","article-title":"A\u00a0human dermal replacement for treatment of diabetic foot ulcers","volume":"9","author":"Pollak","year":"1997","journal-title":"Wounds"},{"issue":"2","key":"10.1016\/j.cpm.2014.09.004_bib26","first-page":"125","article-title":"Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context","volume":"26","author":"Allenet","year":"2000","journal-title":"Diabetes Metab"},{"issue":"5","key":"10.1016\/j.cpm.2014.09.004_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1067-2516(02)80047-3","article-title":"Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis","volume":"41","author":"Hanft","year":"2002","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"6","key":"10.1016\/j.cpm.2014.09.004_bib28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diacare.26.6.1701","article-title":"The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers, results from a prospective randomized trial","volume":"26","author":"Marston","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpm.2014.09.004_bib29","unstructured":"Soluble Systems. TheraSkin: real skin wound therapy. SWAI, 2011. Available at: http:\/\/www.solublesystems.com\/Products\/TheraSkin. Accessed June 6, 2014."},{"key":"10.1016\/j.cpm.2014.09.004_bib30","first-page":"184","article-title":"A\u00a0prospective comparison of diabetic foot ulcers treated with either cryopreserved skin allograft or bioengineered skin substitute","volume":"23","author":"DiDomenico","year":"2011","journal-title":"Wounds"},{"key":"10.1016\/j.cpm.2014.09.004_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0031-1289167","article-title":"Acellular dermal matrix and negative pressure wound therapy: a tissue-engineered alternative to free tissue transfer in the compromised host","volume":"28","author":"Menn","year":"2012","journal-title":"J\u00a0Reconstr Microsurg"},{"key":"10.1016\/j.cpm.2014.09.004_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.bcr.0000192265.20514.c5","article-title":"Fourth degree burns to the lower extremity with exposed tendon and bone: a ten-year experience","volume":"1","author":"Parrett","year":"2006","journal-title":"J\u00a0Burn Care Res"},{"issue":"4","key":"10.1016\/j.cpm.2014.09.004_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/01.prs.0000204959.18136.36","article-title":"Lower extremity trauma: trends in the management of soft tissue reconstruction of open tibia-fibula fractures","volume":"117","author":"Parrett","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jbm.820140108","article-title":"Design of an artificial skin. I. Basic design principles","volume":"14","author":"Yannas","year":"1980","journal-title":"J\u00a0Biomed Mater Res"},{"key":"10.1016\/j.cpm.2014.09.004_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jbm.820140203","article-title":"Design of an artificial skin. II. Control of chemical composition","volume":"14","author":"Yannas","year":"1980","journal-title":"J\u00a0Biomed Mater Res"},{"issue":"4","key":"10.1016\/j.cpm.2014.09.004_bib36","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.prs.0000304237.54236.66","article-title":"Integra in lower extremity reconstruction after burn injury","volume":"121","author":"Lee","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.jfas.2005.10.005","article-title":"Dermal regeneration template in the surgical management of diabetic foot ulcers: a series of five cases","volume":"45","author":"Silverstein","year":"2006","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"Suppl","key":"10.1016\/j.cpm.2014.09.004_bib38","doi-asserted-by":"crossref","first-page":"232S","DOI":"10.1097\/PRS.0b013e3182615703","article-title":"Wound healing in the upper and lower extremities: a systematic review on the use of acellular dermal matrices","volume":"130","author":"Iorio","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.cpm.2014.09.004_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1742-481X.2011.00878.x","article-title":"Treatment of chronic heel osteomyelitis in vasculopathic patients: can the combined use of Integra, skin graft and negative pressure wound therapy be considered a valid therapeutic approach after partial tangential calcanectomy?","volume":"9","author":"Fraccalvieri","year":"2012","journal-title":"Int Wound J"},{"key":"10.1016\/j.cpm.2014.09.004_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1742-481X.2010.00670.x","article-title":"The use of dermal substitute to preserve maximal foot length in diabetic foot wounds with tendon and bone exposure following urgent surgical debridement for acute infection","volume":"7","author":"Clerici","year":"2010","journal-title":"Int Wound J"},{"key":"10.1016\/j.cpm.2014.09.004_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1742-4801.2005.00099.x","article-title":"Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience","volume":"2","author":"Martin","year":"2005","journal-title":"Int Wound J"},{"key":"10.1016\/j.cpm.2014.09.004_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.ASW.0000323532.98003.26","article-title":"A\u00a0multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds","volume":"21","author":"Winters","year":"2008","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.cpm.2014.09.004_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1742-481X.2006.00209.x","article-title":"The use of acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study","volume":"3","author":"Brigido","year":"2006","journal-title":"Int Wound J"},{"key":"10.1016\/j.cpm.2014.09.004_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1742-481X.2009.00585.x","article-title":"Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomized, multicenter study","volume":"6","author":"Reyzelman","year":"2009","journal-title":"Int Wound J"},{"issue":"5","key":"10.1016\/j.cpm.2014.09.004_bib45","first-page":"111","article-title":"Living cells of collagen matrix: which is more beneficial in the treatment of diabetic foot ulcers?","volume":"20","author":"Landsman","year":"2008","journal-title":"Wounds"},{"key":"10.1016\/j.cpm.2014.09.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.wndm.2013.10.008","article-title":"Dehydrated human amnion\/chorion membrane allografts in patients with chronic diabetic foot ulcers: a long-term follow-up study","volume":"4","author":"Zelen","year":"2014","journal-title":"Wound Med"},{"key":"10.1016\/j.cpm.2014.09.004_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/iwj.12242","article-title":"A\u00a0prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnio\/chorion membrane allograft in the management of diabetic foot ulcers","volume":"11","author":"Zelen","year":"2014","journal-title":"Int Wound J"},{"key":"10.1016\/j.cpm.2014.09.004_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5966\/sctm.2011-0018","article-title":"Concise review: role of mesenchymal stem cells in wound repair","volume":"1","author":"Maxson","year":"2012","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.cpm.2014.09.004_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1534734614534977","article-title":"Angiogenic effect of mesenchymal stem cells as a therapeutic target for enhancing diabetic wound healing","volume":"13","author":"Gu","year":"2014","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.cpm.2014.09.004_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2011.10.032","article-title":"The role of stem cells in diabetic foot ulcers","volume":"96","author":"Blumberg","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.cpm.2014.09.004_bib51","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jor.21385","article-title":"Topical embryonic stem cells enhance wound healing in diabetic rats","volume":"9","author":"Lee","year":"2011","journal-title":"J\u00a0Orthop Res"},{"issue":"7S","key":"10.1016\/j.cpm.2014.09.004_bib52","doi-asserted-by":"crossref","first-page":"239S","DOI":"10.1097\/01.prs.0000222891.74489.33","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"117","author":"Sheehan","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"7s","key":"10.1016\/j.cpm.2014.09.004_bib53","doi-asserted-by":"crossref","first-page":"152S","DOI":"10.1097\/01.prs.0000222534.79915.d3","article-title":"The efficacy of Apligraf in the treatment of diabetic foot ulcers","volume":"117","author":"Dinh","year":"2006","journal-title":"Plast Reconstr Surg"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842214000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842214000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:56:32Z","timestamp":1760208992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842214000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0891842214000779"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2014.09.004","relation":{},"ISSN":["0891-8422"],"issn-type":[{"value":"0891-8422","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineered Alternative Tissues in Diabetic Wound Healing","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}